Antimicrobial Resistance New Antibiotic Options Show Promise Against Biothreat PathogensGlobal Biodefense StaffSeptember 12, 2025
Medical Countermeasures Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense PreparednessGlobal Biodefense StaffSeptember 9, 2025
Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore Medical Countermeasures October 18, 2023 …
Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster Medical Countermeasures September 20, 2023 …
Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant Contracts + Grants September 17, 2023 …
Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve Medical Countermeasures September 13, 2023 …
HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies Contracts + Grants September 8, 2023 …
Kyasanur Forest Disease: Promising Experimental Vaccine for Rare Tick-borne Flavivirus Medical Countermeasures September 7, 2023 …
Disease X: CEPI and University of Oxford Collaborate on Rapid Response Vaccine Technology Medical Countermeasures August 29, 2023 …
Chikungunya Vaccine: Health Canada Moves Forward with Valneva Review Medical Countermeasures August 29, 2023 …
CSL Seqirus Awarded Contract for Influenza A(H5N8) Candidate Vaccine Medical Countermeasures August 28, 2023 …
Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines Medical Countermeasures August 28, 2023 …
NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques Medical Countermeasures August 25, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy Industry News August 22, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
RedHill Biopharma Highlights Federal Medical Countermeasure Investments Industry News August 17, 2023 …
